December 08, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the resignation of Steven McAllister from the position of Chief Financial Officer effective December 31, 2016. He has indicated he will be transitioning to a new opportunity at a privately-held medical device company. In connection with his departure, the Company has appointed Melanie […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone